Envoy Medical, Inc. / Fundamentals

    Income statement

    Net revenue
    €190.57K
    Cost of goods sold
    €246.37K
    Gross profit
    -€499.61K
    SG&A expenses
    €7.41M
    R&D expenses
    €8.98M
    EBITDA
    -€12.72M
    D&A
    €156.24K
    EBIT
    -€16.89M
    Interest expenses
    €1.52M
    EBT
    -€18.26M
    Tax expenses
    €0.00
    Net income
    -€18.26M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €3.59M
    Changes in working capital
    €740.84K
    Operating cash flow
    -€13.20M
    Capex
    €75.54K
    Other investing cash flow
    €0.00
    Net investing cash flow
    -€75.54K
    Total cash dividends paid
    -€2.09M
    Issuance of common stock
    €175.12K
    Debt repayment
    €14.82M
    Other financing cash flow
    €3.29M
    Net financing cash flow
    €16.32M
    Foreign exchange effects
    €858.44
    Net change in cash
    €3.04M
    Cash at end of period
    €4.54M
    Free cash flow
    -€13.13M

    Balance sheet

    Cash and cash equivalents
    €4.54M
    Cash and short-term investments
    €4.54M
    Total receivables
    €36.91K
    Inventory
    €1.36M
    Other current assets
    €511.63K
    Total current assets
    €6.45M
    Property, plant & equipment
    €1.69M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €363.12K
    Total non-current assets
    €2.05M
    Total assets
    €8.50M
    Accounts payable
    €1.39M
    Short-term debt
    €169.97K
    Other current liabilities
    €5.31M
    Total current liabilities
    €6.87M
    Long-term debt
    €603.49K
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €26.66M
    Total non-current liabilities
    €27.26M
    Total liabilities
    €34.13M
    Common stock
    €1.72K
    Retained earnings
    -€255.74M
    Other equity
    -€102.15K
    Total equity
    -€25.63M
    Total liabilities and shareholders' equity
    €8.50M

    Company information

    Market capitalization
    €39.99M
    Employees
    34
    Enterprise Value
    €26.53M

    Company ratios

    Gross margin
    -262.2%
    EBITDA margin
    -6,673.0%
    EBIT margin
    -8,862.6%
    EBT margin
    -9,579.3%
    Net margin
    -9,579.3%
    ROE
    71.2%
    ROA
    -214.8%
    Asset turnover
    2.2%
    FCF margin
    -6,967.6%
    FCF yield
    -33.2%
    Efficiency ratio
    6,773.0%
    Net sales per employee
    €5.61K
    Net income per employee
    -€536.93K

    Notifications